We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mobile Phone Messaging to Improve Women's and Children's Health (Mobile WACh) in Kenya (Mobile WACh)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01894126
First Posted: July 9, 2013
Last Update Posted: November 9, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
University of Nairobi
Kenyatta National Hospital
Information provided by (Responsible Party):
Jennifer Unger, University of Washington
  Purpose
With the increased prevalence of cellular phones, mobile technology provides an important tool to reach underserved populations in low to middle income countries. mHealth interventions offer promise to improve maternal child health throughout the reproductive health continuum if they contribute to increasing skilled birth attendance, family planning and exclusive breastfeeding. We propose a randomized clinical trial to determine effect of using mobile phones to deliver SMS (one-way) versus an interactive SMS dialogue (two-way) on uptake of reproductive and neonatal health services and maternal and infant outcomes

Condition Intervention
Maternal Health Neonatal Health Family Planning Behavioral: Two-way SMS Dialogue Behavioral: One-way SMS Messaging

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Mobile Phone One Way Short Message Service (SMS) Versus SMS Dialogue for Women's and Child Health (Mobile WACh) in Kenya: A Randomized Control Trial

Resource links provided by NLM:


Further study details as provided by Jennifer Unger, University of Washington:

Primary Outcome Measures:
  • Contraceptive uptake [ Time Frame: 10 weeks postpartum; 24 weeks postpartum ]
  • Facility Delivery [ Time Frame: Postpartum ]
  • Exclusive Breastfeeding [ Time Frame: 24 weeks postpartum ]

Secondary Outcome Measures:
  • ANC attendance [ Time Frame: Postpartum ]
  • Infant Immunizations [ Time Frame: Six months postpartum ]
  • Maternal mortality [ Time Frame: 6 months postpartum ]
  • Infant mortality [ Time Frame: Six months postpartum ]

Enrollment: 300
Study Start Date: July 2013
Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Two-way SMS dialogue
Women will receive SMS messages with prompts to reply. They will have the ability to text back to the system and both respond to and initiate SMS dialogue
Behavioral: Two-way SMS Dialogue
Experimental: One-way SMS Messaging
Women will receive scheduled one-way SMS messages
Behavioral: One-way SMS Messaging
No Intervention: Control

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Pregnant
  • Access to a mobile phone
  • Able to read SMS messages
  • Willing to receive SMS messages

Exclusion Criteria:

  • Unwilling or unable to meet inclusion criteria
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01894126


Locations
Kenya
Mathare North Health Centre
Nairobi, Kenya
Sponsors and Collaborators
University of Washington
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
University of Nairobi
Kenyatta National Hospital
  More Information

Responsible Party: Jennifer Unger, Assistant Professor, University of Washington
ClinicalTrials.gov Identifier: NCT01894126     History of Changes
Other Study ID Numbers: K12HD001264-14UNGER
K12HD001264-14 ( U.S. NIH Grant/Contract )
First Submitted: July 2, 2013
First Posted: July 9, 2013
Last Update Posted: November 9, 2016
Last Verified: November 2016